Trial Profile
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Lenalidomide; Vorinostat
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Jan 2016 New trial record